1. Home
  2. Live Updates
  3. Yifan pharma

Live Breaking News & Updates on Yifan Pharma

Stay updated with breaking news from Yifan pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Week In Review: SystImmune Out-Licenses Global Rights For ADC To BMS In $8.4B Deal

Week In Review: SystImmune Out-Licenses Global Rights For ADC To BMS In $8.4B Deal
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

South Korea , United States , Fosun Pharma , Chugai Pharma , Cstone Pharma , Yifan Pharma , Biokin Pharma , Bristol Myers Squibb , Shanghai Alebund Pharmaceuticals , Global Health Innovative Technology Fund , Nona Biosciences Harbour Mice , Greater Mekong Subregion , Southeast Asia , Alebund Pharmaceuticals ,

Two Of Aurobindo's Europe Biosimilar Filings Stuck, Licenses Ryzneuta From Yifan Pharma :: Scrip

Two Of Aurobindo's Europe Biosimilar Filings Stuck, Licenses Ryzneuta From Yifan Pharma :: Scrip
informa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from informa.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Andhra Pradesh , Sarath Chandra Reddy , Yifan Pharma , Ashish Anvekar , Simon Li , Aurobindo Curateq Biologics , Satakarni Makkapati , Acrotech Biopharma , P Sarath Chandra Reddy , Yugandhar Puvvala , Aurobindo Pharma , Aurobindo Pharma United States Inc , Sun Pharmaceutical Industries Ltd , Roche Holding Ag Avastin , Regulatory Agency , Astellas Pharma Inc , While Bristol Myers Squibb Company Revlimid , Amgen Inc , Information Technology , Eugia Pharma Specialities Ltd , European Medicines Agency , Us Food Drug Administration , Aurobindo Pharma Limited , Lecanemab Challenger , Migraine Buster And Lipid Lowering ,

Week In Review: Fosun Signs $840 Million Deal For U.S. Rights To Henlius' PD-1

Shanghai Fosun Pharma announced it has licensed US rights to a PD-1 candidate from its longstanding partner Henlius Biotech in an $840 million agreement. Read more here. ....

United States , Yifan Pharma , Marinus Ztalmy , Marinus Pharma , Xiaochun Yu , Fosun Pharma , Zhuhai Biotheus , Jiangsu Hansoh Pharma , Simcere Pharma , Company News , Research Laboratory , Innovative Technology , Scientific Lab For Medicine , Modern Medical Research Laboratory , Two Scientists Wearing Face Masks , Analyse Sample , Petri Dish , Discuss Innovative , Advanced Scientific Lab , Henlius Biotech , Although Fosun , Evive Biotechnology , Acrotech Biotech , Granulocyte Colony Stimulating Factor , Hansoh Pharma , Lupeng Pharmaceutical ,